¼¼°èÀÇ Å×Å©³×Ƭ-99m ½ÃÀå º¸°í¼­(2025³â)
Technetium-99m Global Market Report 2025
»óǰÄÚµå : 1811045
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,348,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,176,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,004,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Å×Å©³×Ƭ-99m ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ¾ÈÁ¤µÈ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â±îÁö CAGR 4.9%·Î È®´ëµÇ¾î 57¾ï 4,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø±â°£¿¡ ¿¹ÃøµÇ´Â ¼ºÀåÀº ÇÙÀÇ·á À̹Ì¡ ±â´ÉÀÇ È®´ë, ³ëÀÎ Áõ°¡, Áø´Ü·® Áõ°¡, ¾Ï ÀÌȯÀ²ÀÇ »ó½Â, ÇÏÀ̺긮µå À̹Ì¡ ½Ã½ºÅÛÀÇ Ã¤¿ë È®´ë µî¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Áö¼Ó °¡´ÉÇÑ µ¿À§ ¿ø¼Ò ±â¼ú °³¹ß, ºñ ¹ÝÀÀ±â ±â¹Ý Á¦Á¶ ¹æ¹ý, ¹æ»ç¼º ÀǾàǰ ±â¼úÀÇ Áøº¸, ÀΰøÁö´É°úÀÇ ÅëÇÕ, ¹æ»ç¼º ÀǾàǰ Á¦Á¶ Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù.

¿µ»ó Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÇâÈÄ Å×Å©³×Ƭ-99m ½ÃÀåÀÇ ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿µ»ó Áø´ÜÀº ü³»¸¦ ½Ã°¢ÀûÀ¸·Î Ç¥ÇöÇÏ´Â ÀÇ·á ±â¼úÀ» Æ÷ÇÔÇϸç, Àǻ簡 ´Ù¾çÇÑ Áõ»óÀ» Áø´ÜÇϰųª ¶§·Î´Â Ä¡·á¸¦ ¾È³»ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡´Â Á¶±âÀûÀ̰í Á¤È®ÇÑ Áø´ÜÀ» ÇÊ¿ä·Î ÇÏ´Â ¸¸¼ºÁúȯÀÇ ¸¸¿¬À¸·Î ÀÎÇÑ °ÍÀÌ Å®´Ï´Ù. Å×Å©³×Ƭ-99mÀº ÇÙÀÇ·á ½ºÄµ¿¡¼­ »ó¼¼ÇÑ ¿µ»ó¸¦ »ý¼ºÇÏ´Â ¹æ»ç¼º Ư¼ºÀ» ÀÌ¿ëÇÏ¿© Àǻ簡 Àå±â¿Í Á¶Á÷ÀÇ ±â´ÉÀ» ³ôÀº Á¤¹Ðµµ·Î ½Ã°¢È­ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ¿µ»ó Áø´ÜÀ» Áö¿øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î ¿µ±¹ Á¤ºÎ ±â°üÀÎ NHS England¿¡ µû¸£¸é 2023³â 3¿ù±â ¿µ±¹ÀÇ ¿µ»ó °Ë»ç °Ç¼ö´Â 4,500¸¸ °ÇÀ¸·Î Àü³â 4,400¸¸ °Ç¿¡¼­ 2.2% Áõ°¡Çß½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¿µ»ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ Å×Å©³×Ƭ-99m ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Å×Å©³×Ƭ-99m ½ÃÀåÀÇ °¢ ȸ»ç´Â º¹ÀâÇÑ º´¸®¿¡ ´ëÇÑ ¿µ»ó Áø´ÜÀÇ Á¤È®¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇØ Ã·´Ü ¹æ»ç¼º ÀǾàǰ À̹Ì¡ ¾à¹°°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾à¹°Àº ¹æ»ç¼º ¹°Áú·Î Ç¥ÁöµÈ Ư¼ö È­ÇÕ¹°À̸ç Àǻ簡 ¿µ»ó ±â¼úÀ» »ç¿ëÇÏ¿© ü³» ±¸Á¶¸¦ ½Ã°¢È­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 6¿ù ¿µ±¹ÀÇ ÀÓ»ó¹æ»ç¼ºÀǾàǰȸ»çÀÎ Serac Healthcare Limited´Â 16¼¼ ÀÌ»óÀÇ ¿©¼º¿¡°Ô Ç¥À缺 º¹¸· Àڱ󻸷ÁõÀÇ °¡½ÃÈ­¿Í Áø´ÜÀ» À§Çؼ­ ¼³°èµÈ Çõ½ÅÀûÀÎ SPECT-CT À̹Ì¡ ¾àÁ¦ÀÎ 99mTc-¸¶¶ó½ÃŬ¶óƼµå¿¡ ´ëÇØ ¹Ì±¹ FDA·ÎºÎÅÍ ÆÐ½ºÆ® Æ®·¢ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. º»Á¦´Â Àڱ󻸷Áõ º´º¯¿¡¼­ °ú¹ßÇöÇϰí ÀÖ´Â ÀÎÅױ׸°¿¡ °áÇÕÇÏ´Â Å×Å©³×Ƭ-99m Ç¥Áö Ç¥Àû ÆéƼµåÀ̸ç, SPECT-CT °Ë»ç¿¡¼­ Áúȯ ºÎÀ§¸¦ ¸íÈ®ÇÏ°Ô °¡½ÃÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̰ÍÀº º¹°­°æ ¼ö¼úÀ» ´ëüÇÏ´Â ºñħ½ÀÀû Áø´Ü ¹æ¹ýÀ» Á¦°øÇϸç Àڱà ³»¸·ÁõÀÌ ÀǽɵǴ ¿©¼º¿¡°Ô ´õ ¾ÈÀüÇÏ°í »ç¿ëÇϱ⠽¬¿î Áø´Ü ¿É¼ÇÀ» ¼³¸íÇÕ´Ï´Ù. Å×Å©³×Ƭ-99mÀÇ ÀÌ»óÀûÀÎ ¹Ý°¨±â³ª °¨¸¶¼± ¹æÃâ ¿¡³ÊÁö µîÀÇ ¾çÈ£ÇÑ È­»ó Ư¼ºÀ» ÀÌ¿ëÇÔÀ¸·Î½á, º» ¾àÁ¦´Â ¹æ»ç¼± ÇÇÆøÀ» ÃÖ¼ÒÈ­Çϸ鼭 °íǰÁúÀÇ Áø´Ü È­»óÀ» ±âÀçÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â¼ú Çõ½Å¿¡ ÀÇÇØ Àڱ󻸷Áõ °ü¸®¿¡¼­ Áø´Ü Á¤¹ÐµµÀÇ Çâ»ó°ú º¸´Ù ÁÁÀº Ä¡·á ¹æÄ§ÀÇ °áÁ¤ÀÌ ±â´ëµÇ´Â °Í°ú µ¿½Ã¿¡, Å×Å©³×Ƭ-99mÀ» ÀÌ¿ëÇÑ È­»ó Áø´ÜÀÇ ¿©¼º ÀÇ·á¿¡¼­ ÀÓ»ó ÀÀ¿ëÀÇ ÆøÀÌ ³Ð¾îÁú °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Technetium-99m (Tc-99m) is a radioactive isotope of technetium commonly used in nuclear medicine for diagnostic imaging. It emits gamma rays that can be detected by a gamma camera, enabling visualization of internal organs and structures. With a short half-life of approximately 6 hours, Tc-99m limits patient radiation exposure while delivering clear imaging results.

The primary products related to technetium-99m include radiopharmaceuticals, diagnostic kits, and generators. Radiopharmaceuticals are radioactive compounds used in medical imaging and therapy for diagnosis or treatment. These are available in various formulations such as liquid, solid, and freeze-dried forms. Applications span single photon emission computed tomography (SPECT), positron emission tomography (PET), oncology, cardiology, neurology, and more. The key end users include hospitals, diagnostic imaging centers, research laboratories, specialized clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The technetium-99m market research report is one of a series of new reports from The Business Research Company that provides technetium-99m market statistics, including technetium-99m industry global market size, regional shares, competitors with a technetium-99m market share, technetium-99m market segments, market trends and opportunities, and any further data you may need to thrive in the technetium-99m industry. This technetium-99m market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The technetium-99m market size has grown strongly in recent years. It will grow from $4.52 billion in 2024 to $4.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth during the historic period can be attributed to the expanding applications of nuclear medicine, rising demand for cancer and cardiac diagnostics, increased dependence on molybdenum-99 supply, growing demand for radiopharmaceuticals, and the heightened use of imaging in clinical trials.

The technetium-99m market size is expected to see steady growth in the next few years. It will grow to $5.74 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth projected for the forecast period can be attributed to expanding nuclear imaging capabilities, an increasing geriatric population, a higher volume of diagnostics, rising cancer incidence, and growing adoption of hybrid imaging systems. Key trends during this period include the development of sustainable isotope technologies, non-reactor-based production methods, advancements in radiopharmaceutical technologies, integration with artificial intelligence, and innovations in radiopharmaceutical manufacturing.

The growing demand for diagnostic imaging procedures is expected to drive the growth of the technetium-99m market moving forward. Diagnostic imaging procedures involve medical techniques that create visual representations of the body's interior, assisting doctors in diagnosing and sometimes guiding treatment for various conditions. This rising demand is largely due to the increasing prevalence of chronic diseases that require early and accurate diagnosis. Technetium-99m supports diagnostic imaging by enabling doctors to visualize organ and tissue functions with high precision, using its radioactive properties to produce detailed images during nuclear medicine scans. For example, according to NHS England, a UK government department, 45.0 million imaging tests were performed in England in the year ending March 2023, reflecting a 2.2% increase compared to the 44.0 million tests conducted the previous year. Thus, the rising demand for diagnostic imaging is fueling the technetium-99m market's growth.

Companies in the technetium-99m market are focusing on developing innovative solutions such as advanced radiopharmaceutical imaging agents to improve the accuracy and accessibility of diagnostic imaging for complex medical conditions. These agents are special compounds labeled with radioactive materials that help doctors visualize internal body structures using imaging techniques. For instance, in June 2024, Serac Healthcare Limited, a UK-based clinical radiopharmaceutical company, received Fast Track Designation from the US FDA for 99mTc-maraciclatide, an innovative SPECT-CT imaging agent designed to visualize and diagnose superficial peritoneal endometriosis in women aged 16 and older. This agent is a technetium-99m-labeled targeted peptide that binds to integrins overexpressed in endometriosis lesions, allowing clear visualization of disease sites during SPECT-CT scans. It offers a non-invasive diagnostic alternative to laparoscopic procedures, providing a safer and more accessible diagnostic option for women suspected of having endometriosis. Utilizing the favorable imaging characteristics of technetium-99m, including its ideal half-life and gamma emission energy, this agent delivers high-quality diagnostic images while minimizing radiation exposure. This innovation is expected to improve diagnostic accuracy and support better treatment decisions in endometriosis management, while broadening the clinical use of technetium-99m-based imaging in women's health.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed sum. Through this acquisition, Telix aims to strengthen its control over the supply chain for key medical isotopes such as technetium-99m by integrating ARTMS's cyclotron-based radioisotope production technology. This move is intended to support large-scale, cost-effective, and reliable production of diagnostic and therapeutic isotopes within Telix's radiopharmaceutical portfolio. ARTMS Inc. is a Canada-based company specializing in advanced cyclotron technologies for producing medical radioisotopes including technetium-99m.

Major players in the technetium-99m market are Cardinal Health Inc., Siemens Healthineers AG, Philips Healthcare , GE Healthcare Technologies Inc. , BWX Technologies Inc., Bracco Imaging S.p.A., Lantheus Holdings Inc., China Isotope & Radiation Corporation (CIRC), Jubilant Pharma Limited, Curium Pharma LLC, Eckert & Ziegler Strahlen, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Isotopia Molecular Imaging Ltd., Advanced Cyclotron Systems Inc., Cyclopharm Limited, SHINE Technologies LLC, Medi-Radiopharma Kft., and SDS Lifesciences Pvt Ltd.

North America was the largest region in the technetium-99m market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in technetium-99m report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the technetium-99m market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The technetium-99m market includes revenues earned by entities by providing services such as diagnostic imaging, functional imaging, medical diagnostic imaging, cardiac imaging, and cancer detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The technetium-99m market also includes sales of technetium-99m sestamibi, mercaptoacetyltriglycine, hexamethylpropyleneamine oxime, technetium-99m pertechnetate, and diethylenetriamine pentaacetic acid. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Technetium-99m Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on technetium-99m market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for technetium-99m ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The technetium-99m market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Technetium-99m Market Characteristics

3. Technetium-99m Market Trends And Strategies

4. Technetium-99m Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Technetium-99m Growth Analysis And Strategic Analysis Framework

6. Technetium-99m Market Segmentation

7. Technetium-99m Market Regional And Country Analysis

8. Asia-Pacific Technetium-99m Market

9. China Technetium-99m Market

10. India Technetium-99m Market

11. Japan Technetium-99m Market

12. Australia Technetium-99m Market

13. Indonesia Technetium-99m Market

14. South Korea Technetium-99m Market

15. Western Europe Technetium-99m Market

16. UK Technetium-99m Market

17. Germany Technetium-99m Market

18. France Technetium-99m Market

19. Italy Technetium-99m Market

20. Spain Technetium-99m Market

21. Eastern Europe Technetium-99m Market

22. Russia Technetium-99m Market

23. North America Technetium-99m Market

24. USA Technetium-99m Market

25. Canada Technetium-99m Market

26. South America Technetium-99m Market

27. Brazil Technetium-99m Market

28. Middle East Technetium-99m Market

29. Africa Technetium-99m Market

30. Technetium-99m Market Competitive Landscape And Company Profiles

31. Technetium-99m Market Other Major And Innovative Companies

32. Global Technetium-99m Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Technetium-99m Market

34. Recent Developments In The Technetium-99m Market

35. Technetium-99m Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â